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Abstract
Background: RDX is a well-known pollutant to induce neurotoxicity. MicroRNAs (miRNA) and messenger RNA
(mRNA) profiles are useful tools for toxicogenomics studies. It is worthy to integrate MiRNA and mRNA expression
data to understand RDX-induced neurotoxicity.
Results: Rats were treated with or without RDX for 48 h. Both miRNA and mRNA profiles were conducted using
brain tissues. Nine miRNAs were significantly regulated by RDX. Of these, 6 and 3 miRNAs were up- and down-
regulated respectively. The putative target genes of RDX-regulated miRNAs were highly nervous system function
genes and pathways enriched. Fifteen differentially genes altered by RDX from mRNA profiles were the putative
targets of regulated miRNAs. The induction of miR-71, miR-27ab, miR-98, and miR-135a expression by RDX, could
reduce the expression of the genes POLE4, C5ORF13, SULF1 and ROCK2, and eventually induce neurotoxicity. Over-
expression of miR-27ab, or reduction of the expression of unknown miRNAs by RDX, could up-regulate HMGCR
expression and contribute to neurotoxicity. RDX regulated immune and inflammation response miRNAs and genes
could contribute to RDX- induced neurotoxicity and other toxicities as well as animal defending reaction response
to RDX exposure.
Conclusions: Our results demonstrate that integrating miRNA and mRNA profiles is valuable to indentify novel
biomarkers and molecular mechanisms for RDX-induced neurological disorder and neurotoxicity.
Introduction
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX), is a well
known contaminant to territory, soil and ground water
due to military and manufacturing activities. A series of
studies have demonstrated that RDX can cause neurotoxi-
city including seizure in human and animals [1-4]. RDX
can also induce immunotoxicity in rats [5-7].
While many effects of RDX exposure are known, the
molecular mechanisms of RDX caused toxicity have not
been well characterized. It appears that RDX binding to
the GABAA receptor convulsant site maybe the primary
mechanism of seizure induction by RDX and that
reduction of GABAergic inhibitory transmission in the
amygdala is involved in the generation of RDX-induced
seizures[8-10]. But more mechanisms still needed to be
studied such as epigenetic mechanisms.
Recently, It was [11] found RDX exposure could sig-
nificantly alter a large number of miRNA expression in
mouse brain and liver tissues with a 28 day long term
exposure. MiRNAs are endogenous, small non-coding
RNAs, usually 18-25 nucleotides long, have been found
to play crucial roles in post-transcriptionally regulation
of mRNA. MiRNAs have been found to involve in
almost all fundamental important biological processes
and diseases including neurological diseases and nervous
system function [12]. MiRNAs carries out its function
by specifically binding 3’UTR of mRNA to interrupt
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mRNA translation or cause degradation of transcripts
[13-15]. Recent reports suggest that miRNA could play
an opposite role by activating a gene expression at cer-
tain conditions [16,17].
We use rat as a model species to investigate the
impact of RDX on both miRNA and mRNA expression
in rat brain tissues with a sub-acute short term exposure
(48 h). The objectives of the study are to see whether we
could see an across species conserved miRNA expres-
sion between rat and mouse, find overlapped targets
between the putative targets of regulated miRNAs and
mRNA genes regulated by RDX, identify early expres-
sion altered miRNAs and genes as new markers for
assessing RDX induced neurotoxicity, and further
understand the molecular mechanisms of RDX caused
neurotoxicity. Since that miRNAs are highly conserved
between humans and rats, this study should improve
our understanding of the molecular mechanisms of
RDX induced neurological disorders and diseases.
There are still very few studies to use miRNA expres-
sion profiles for characterizing RDX caused toxicity.
There is no report to integrate RDX altered miRNA and
mRNA expression profiles.
Materials and methods
Chemical
RDX (purity > 99%) was obtained from Stan Caulder
(Naval Surface Warfare Center, Indianhead, MD, USA).
Animals and Treatment
Female Sprague-Dawley rats (175-225 grams) were from
the in-house breeding colony (College of Pharmacy,
University of Louisiana at Monroe [ULM] and treated in
accordance with the Guide for Use and Care of Animals
[18]. Breeders were from Harlan-Sprague Dawley in
Madison, WI. Housing consisted of a 12 h light/dark
cycle with ad libitum access to tap water and rodent
chow (Harlan/Teklad 7012, Madison, WI). Rats were
housed individually in polycarbonate cages on hardwood
bedding (Sani-chips, Harlan/Tekland, Madison, WI) one
week prior to treatment. Food was withdrawn the night
before treatments, which were administered by gavage
between 8 and 10 AM. Study protocols were preap-
proved by the Institutional Animal Care and Use Com-
mittee of the University of Louisiana at Monroe
(Animal Welfare Assurance Number A3641-01).
Groups of rats were weighed and randomly assigned
to treatment. Treatments were vehicle (5% v/v DMSO
in corn oil), RDX (47 mg/kg). Rats were observed con-
tinuously for the first hour after dosing, hourly for 8 h
and daily thereafter. Moribund rats were euthanized
with CO2. At 48 hours after treatment, survivors were
anesthetized with CO2. A portion of the brain was
removed and flash frozen in liquid N2 and stored at -70º
C for miRNA and mRNA microarray analyses.
Total RNA extraction
Total RNA was extracted from about 30 mg of brain tissue.
Tissues were homogenized in the lysis buffer with FAST
Prep-24 from MP before using RNeasy kits (Qiagen). Total
RNA concentrations were measured using NanoDrop®
ND-1000 Spectrophotometer (NanoDrop technologies,
Wilmington, DE, USA). The integrity and quality of total
RNA was checked on an Agilent 2100 Bioanalyzer (Palo
Alto, CA). The gel-like images generated by the Bioanaly-
zer show that total RNAs have two bands, represent 18S
and 26S RNA of mammalian RNA. Nuclease-free water
(Ambion) was used to elute total RNA.
MicroRNA extraction
We extracted total miRNA from each sample using the
mirVana miRNA Isolation Kit (Ambion, Austin, TX)
according to the manufacturer’s instructions. Briefly,
0.03-0.05 g tissues were weighed and placed in a new
2-mL micro-centrifuge tube, followed by adding 300 μL
lysis/binding buffer. Then, the tissues were thoroughly
disrupted and homogenized using a Sonic Dismembra-
tor (model 100, Fisher Scientific, Atlanta, GA). After
homogenization, we added 30 μL miRNA homogenate
additive to each tissue lysate, vortexed it for 10 sec, and
then incubated it on ice for 10 min. After washing, we
eluted the total RNAs using 100 μL elution buffer pro-
vided in the miRNA isolation kit. We performed all
these operations on ice. The extracted RNA was quanti-
fied using a NanoDrop ND-100 spectrophotometer
(NanoDrop Technologies, Wilmington, DE), aliquoted,
and immediately stored at −80°C until analysis.
MicroRNA microarray hybridization
The miRNA micro-array analysis was performed by LC
Sciences (Houston, TX) as described previously [11].
Briefly, the assay started with approximately 6 μg total
RNA. After the total RNAs were fractionated by size
using a YM-100 Microcon centrifugal filter (Millipore,
Billerica, MA), poly(A) tails were added to RNA
sequences with lengths less than 300 nucleotides using
poly(A) polymerase. Then, an oligonucleotide tag was
ligated to the poly(A) tail for later fluorescent dye stain-
ing. RNA samples from brain extracts were hybridized
overnight using two different tags on a μParaflo micro-
fluidic chip using a microcirculation pump developed by
Atactic Technologies (Houston, TX).
mRNA microarray hybridization
mRNA microarray hybridization was done as described pre-
viously[19]. Briefly cDNA from 1 ug total RNA was synthe-
sized, hybridized to arrays, and detected by secondary
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hybridization to Alexa647 and Cy3 dendrimer oligonu-
cleotides using an Array900 detection kit per manufac-
turer’s instructions (Genisphere, Hatfield, PA). cDNA was
hybridized to 8 K Sigma/Compugen rat 70-mer oligonu-
cleotide libraries arrayed on glass slides (Center for
Applied Genomics, Newark, NJ http://www.cag.icph.org/).
MiRNA microarray data analysis
MiRNA microarray was normalized by Lowess normal-
ization algorithm using GeneSpring 10.0 (Agilent Tech-
nologies, Foster City, CA, USA). We first filtered
substance according to flags. All substances that were
at least 50% of samples in any of 2 out of 2 conditions
(control group and RDX treatment group) have present
calls according to the feature extraction software data
will be remained. 215 substances were left after the flag
filtering. We also judged a miRNA detectable using at
least three criteria: a) signal intensity bigger than three
times background standard deviation; b) spot coeffi-
cient of variance (CV) < 0.5, in which we calculated
CV as (standard deviation)/(signal intensity); and c) at
least two spots of four technical repeats in each chip
and two of three biological replicates in either control
or treatment group have signal greater than three
times background standard deviation. We found that
178 miRNAs could be detected in either control or
treatment group, and were also in the 215 miRNA list.
Therefore, 178 detected miRNAs were employed to
identify differentiated miRNAs in rat brain after expo-
sure to RDX. Differentiated miRNAs were computed
using un-paired T-test with a cut off p value <= 0.05
and fold change >=1.2 (corrected by Benjamini Hochberg
at a FDR <= 0.05).
MRNA microarray data analysis
MRNA microarray data analysis was done as we described
previously [20,21]. Briefly, the data was normalized based
on Lowess normalization method, Bayesian statistical ana-
lysis with 5% FDR was used to identify differential genes
between two groups.
MiRNA target prediction
Three algorithms were used to predict target genes of miR-
NAs. These three algorithms are miRBase [22], TargetScan
[23] and PicTar [24].
Reverse-transcription quantitative PCR (QRT-PCR)
We selected miRNAs with aberrant expression in micro-
array analysis and then validated them using qRT-PCR
on an ABI7300 system (Applied Biosystems, Foster City,
CA). We used TaqMan miRNA assays to detect and
quantify mouse miRNAs using stem-loop RT-PCR
according to the manufacturer’s instructions.
Gene functional analysis and network construction
Physiological process and pathway analyses were per-
formed using the Ingenuity pathway analysis (IPA) tool. A
physiological process or a pathway with an enrichment
p value <= 0.05 was considered to be significant (Ingenuity
Systems, Inc., Redwood City, CA). Gene networks were
constructed based on the IPA tool. A score was assigned
to a network according to the fit of the original set of sig-
nificant genes. This score reflects the negative logarithm
of the p value that indicates the likelihood of the focus
genes in a network being found together due to random
chance [25].
Results
Regulation of miRNA expression in the brain tissues of
rats exposed to RDX
To determine whether the expression profile of miRNAs
changes in response or RDX, we analyzed global expres-
sion of mature miRNAs in the brain tissues of rats trea-
ted with RDX. Rats were treated with RDX at a dose
(47 mg/kg) for 48 h. Three control and treatment ani-
mals were used. Brain tissues from treated and control
rats were used for miRNA profiling. There were 344 rat
miRNAs and 50 control molecules, and each miRNA
was represented by 4 technical replicated spots on each
chip. The Lowess normalization was employed to
remove the systematic error of the experiments. Regardless
control (Figure 1A) or RDX (Figure 1B) treated samples,
the original data showed a clear bias skewed distribution.
After the normalization, the bias distribution was removed
in both control (Figure 1A) and RDX (Figure 1B) treated
samples. Nine miRNAs were differentially regulated by
RDX with a cut off p values (<= 0.05) and fold change (>=
1.2) (Table 1). Of these 9 miRNAs, 6 miRNAs including
miR-98, miR-27b, miR135a, miR-7a, miR-674-5p and
miR-27a were significantly up-regulated by RDX. The
expression of miR-320, miR-129* and miR-342-3p was sig-
nificantly down-regulated by RDX.
Using these 9 miRNAs, we performed a two-way hier-
archical clustering analysis. The samples were divided into
two clusters: three control samples were in a one cluster
and three RDX treated sample were in the other cluster.
The 9 miRNAs were also grouped into two clusters: 6 up-
regulated miRNAs in a cluster and 3 down-regulated miR-
NAs in the other cluster (Figure 2).
Computational predictions of the putative targets of
regulated miRNAs
In order to identify the putative targets or regulated miR-
NAs, we selected three most popular computational algo-
rithms: miRBase, PicTar and TargetScan. We chose target
genes based on a target gene that was recognized by at
least two algorithms. In addition, we also counted target
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genes that were targeted by two or more of these regulated
miRNAs. A total of 1589 target genes were predicted.
Based on the IPA tool, we analyzed the physiological
development and function categories of these target genes.
Top significant enriched development and function terms
were presented in Figure 3A. We could observe that the
nervous system development and function category in the
top list, which included 256 target genes (Additional file 1)
of the miRNAs. Another function category behavior which
is also associated with brain function was in the top list,
which contained 86 genes.
Figure 3B exhibited top 10 significant canonical path-
ways enriched in the 1589 target genes. Among them,
two canonical pathways axonal guidance signaling and
reelin signaling in neurons were clearly involved in ner-
vous system function. Seventy six target genes (Addi-
tional file 2) fell into the axonal signaling pathway
which is related to neurotransmitters and other nervous
System Signaling. Twenty-two genes (Additional file 2)
play a role in reelin signaling in neurons pathway.
In order to find out the interaction between target
genes, we generated common networks using the IPA
software. The target genes of the regulated miRNAs by
RDX were uploaded into the IPA software tool. Net-
works formed by these genes were then mathematically
generated according to their connectivity. Figure 4 illus-
trates the graphical representation of themolecular rela-
tionships between genes, which is one of gene networks
Figure 1 Impact of normalization on the data distribution of control (A) and RDX treated (B) samples. Lowess normalization algorithm
was employed and bias skewed data distribution was observed in both control (A) and RDX treated (B) original samples, but was removed in
the normalized samples.
Table 1 Significantly regulated miRNAs in rat brain after
exposure to RDX.
MiRNA name p-value Fold change Regulation
miR-98 0.006792 1.715814 up
miR-27b 0.029563 1.59366 up
miR-135a 0.019873 1.542563 up
miR-7a 0.048486 1.349329 up
miR-674-5p 0.009661 1.263634 up
miR-27a 0.041365 1.227918 up
miR-320 0.04012 -1.582334 down
miR-129* 0.039644 -1.476831 down
miR-342-3p 0.026962 -1.28396 down
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developed by IPA with the highest score (39). The net-
work is associated with cellular development, nervous
system development and function, organism develop-
ment. Several transcription factors such as DLX2, SOX2,
NKX2-2, PAX6, OTX2, BTG1 and BTG2, and protein
kinases such as PTRZ1, MAPK14 were found to be
involved in the network especially related to nervous
system development and function. This network also
exhibited that many of these genes were regulated by
each other either directly or indirectly.
Figure 2 Hierarchical clustering of differentially expressed miRNAs induced by RDX. Nine differentially expressed miRNAs (horizontal axis)
were used for a Two-Way hierarchical clustering across all the control and RDX treated samples (vertical axis). A Pearson correlation algorithm
was applied to calculate the distances between transcripts or between conditions. The relative level of gene expression is indicated by the color
scale at the right side.
Figure 3 Most significantly physiological processes (A) and canonical pathways (B) of the putative target genes of RDX regulated
miRNAs. Top ten physiological processes (A) and pathways (B) were selected to present. The putative target genes of RDX regulated miRNAs in
rat brain tissues were used to run the Ingenuity pathway tool. The bigger the -log(p-value) of a pathway is, the more significantly the
physiological process or pathway is regulated. The threshold lines represent a p value with 0.05.
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Comparison of miRNA target genes and mRNA expression
profile
The overlap between putative targets of miRNAs and
the expression of mRNAs offers the further information
on the biological processes and specific miRNA regu-
lated gene networks. To reach the goal, we also con-
ducted mRNA microarray analysis. Rats were treated
with or without RDX at (47 mg/kg) for 48 h, subse-
quently the mRNA level of different genes in the brain
tissues were monitored by cDNA micorarray techniques
with approximately 8,000 probes. Using a Bayesian sta-
tistical analysis with 5% FDR, a total of 123 genes were
significantly regulated by RDX. Of these genes, 60 genes
were up-regulated (Additional file 3) and 63 genes were
down-regulated (Additional file 4). In total, 15 (12.2%)
of these regulated genes were putative targets of miR-
NAs regulated by RDX. Ten and 5 of these overlapped
genes were down-regulated and up-regulated by RDX
respectively (Table 2). This relationship maybe inverse,
for instance, down-regulated miRNAs and over-expressed
targets and up-regulated miRNAs and down-regulated
Figure 4 Gene network of the putative target genes of RDX regulated miRNAs. The putative target genes of RDX induced differentially
expressed miRNAS were used to run the IPA tool for gene network analysis. The orange highlighted genes are involved in nervous system
development function. The networks score described in Materials and Methods for the network is 39. The solid lines connecting molecules here
represents a direct relation and dotted lines an indirect relation.
Table 2 Overlapped genes between putative target genes
of miRNAs and differential mRNA genes regulated by
RDX.
Symbol Entrez Gene Name Regulation
HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase Up
LITAF lipopolysaccharide-induced TNF factor Up
NPTX2 neuronal pentraxin II Up
SLC38A2 solute carrier family 38, member 2 Up
VGF VGF nerve growth factor inducible Up
BANP BTG3 associated nuclear protein Down
C5ORF13 chromosome 5 open reading frame 13 Down
CALD1 caldesmon 1 Down
CEP350 centrosomal protein 350 kDa Down
FAM82A2 family with sequence similarity 82, member A2 Down
KIAA1033 KIAA1033 Down
POLE4 polymerase (DNA-directed), epsilon 4 (p12
subunit)
Down
ROCK2 Rho-associated, coiled-coil containing protein
kinase 2
Down
SLC35E4 solute carrier family 35, member E4 Down
SULF1 sulfatase 1 Down
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targets. As shown in table 3 the targets of miR-135a, miR-
98, and most of the targets of miR-7a have an inverse rela-
tionship with their responsive miRNAs. However, some
positive relationship also occurred here. MiR-320, rno-
miR-129* and their targets were both repressed by RDX.
Rno-miR-647-5p and its target gene VGF were both
induced by RDX (Table 3).
Biological functional analysis revealed that more than half
(8) of the overlapped genes are involved in neurological
diseases and nervous system function (Table 4). These
genes included HMGCR, BANP, C5ORF13, ROCK2,
LITAF, POLE4, SULF1 and VGF.
Comparative pathway and network analysis
Besides identifying common genes between putative target
genes of regulated miRNAs and mRNA expression, we
further compared common pathways. Pathway analyses
were performed using the IPA tool. Two gene lists: puta-
tive target genes of regulated miRNAs and differential
genes from the mRNA microarray profiles were uploaded
into the IPA tool for pathway mapping. Based on all
mapped pathways, 52 pathways were shared by these two
gene lists (Figure 5A), which is 61.9% of the 84 mapped
pathways of the mRNA genes regulated by RDX. Using
only significantly mapped pathways (p value <= 0.05),
5 pathways were overlapped (Figure 5B), which is 55.6% of
Table 3 The relationship between miRNAs and their
target genes regulated by RDX.
MiRNAs Target Genes
Names Regulation Up Down
miR-135a Up KIAA1033, CEP350,
ROCK2
miR-320 Down BANP, CALD1, POLE4
miR-98 Up SULF1
miR-129* Down BANP, FAM82A2
miR-27ab Up HMGCR, LITAF,
NPTX2
CALD1, C5orf13,
KIAA1033
miR-342-
3P
Down VGF KIAA1033
miR-7a Up SLC38A2 POLE4, SLC35E4,
C5orf13
miR-674-
5p
Up VGF
Table 4 Over half (8) of the overlapped target genes are involved in neurological disease and nervous system
function.
Category Function Annotation P-value Molecules #
Molecules
Neurological Disease granular cell tumor 1.98E-
03
HMGCR 1
Neurological Disease Huntington’s disease 2.04E-
03
BANP, C5ORF13, HMGCR, ROCK2 4
Neurological Disease subarachnoid hemorrhage 2.98E-
03
HMGCR 1
Neurological Disease neurofibromatosis 6.93E-
03
HMGCR 1
Neurological Disease neurological disorder 1.11E-
02
BANP, C5ORF13, HMGCR, LITAF, POLE4,
ROCK2
6
Neurological Disease meningitis 1.68E-
02
POLE4 1
Neurological Disease Charcot-Marie-Tooth disease 2.16E-
02
LITAF 1
Neurological Disease medulloblastoma 3.90E-
02
POLE4 1
Neurological Disease migration of brain cancer cell
lines
4.09E-
02
C5ORF13 1
Neurological Disease stroke 4.19E-
02
HMGCR 1
Neurological Disease neuropathy 4.77E-
02
HMGCR, LITAF 2
Nervous System Development and
Function
morphology of dendritic spines 9.89E-
03
ROCK2 1
Nervous System Development and
Function
sprouting of neurites 2.07E-
02
SULF1 1
Nervous System Development and
Function
differentiation of neurons 2.42E-
02
C5ORF13, VGF 2
Nervous System Development and
Function
retraction of neurites 4.57E-
02
ROCK2 1
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the 14 significant pathways of the mRNA genes affected by
RDX. The five common significant pathways are shown in
Figure 5C. Clearly we could observe one significant path-
way seaphorin signaling in neurons is involved in neural
system function.
Interestingly, a large group of genes regulated by RDX
through the mRNA profiles were immune and inflam-
matory response genes. For example, the most signifi-
cantly regulated pathway for the regulated mRNA gene
list (Figure 5C) was acute phase response signaling. But
most of these immune and inflammatory response genes
were not significantly represented in the putative target
genes of miRNAs regulated by RDX. MiRNAs may
indirectly regulate these mRNA genes through directly
regulating other genes. Using both immune and inflam-
matory response genes from both putative target genes
of regulated miRNAs and regulated mRNA genes, a
gene network was constructed (Figure 6). We could
obviously see the gene interaction between these two
sources of genes. For example, the putative target gene
IL10 could regulate mRNA genes TIMP1, GZMB and
TNF. TNF could also regulate putative target genes
MNT and DUSP5 to carry out immune and inflamma-
tory functions.
Verification of miRNA microarray responses using real
time QRT-PCR
To verify miRNA microarray results, we selected 4 miR-
NAs to perform real time quantitative PCR (QRT-PCR)
for the RDX exposed brain samples and their controls.
As illustrated in Figure 7, miR-27b and miR-7a were
up-regulated whereas miR-343-3p and miR-320 were
down-regulated by RDX. The QRT-PCR results were
consistent with the miRNA microarray results (Table 1).
Discussion
MiRNA alteration in response to RDX exposure
This is the first report that comprehensively analyzes the
rat brain miRNA expression profile in response to RDX
exposure. We found that 9 miRNAs whose expression
was altered in rat brain tissues by RDX. Among them,
6 miRNAs were up-regulated and 3 miRNAs were
down-regulated. Two miRNAs miR-98 and miR-7a were
induced in rat brain tissues after exposure to RDX, and
they were also up-regulated in mouse brain tissues trea-
ted with RDX [11]. MiR-27b and miR-320 were up-
regulated and down-regulated respectively in our study,
but not significantly changed in mouse brain tissue.
However they were altered in mouse liver tissues with
the same direction as rat brain tissues by RDX. Some of
our regulated miRNA are not shown in Zhang’s regu-
lated miRNA lists, and also RDX induced much more
miRNAs in mouse brain than our case. This should not
be hard to explain, because Zhang’s study is a long term
exposure (28 days), we only used 2 day short exposure.
It may also have dose and species specific responses.
Some of these 9 regulated miRNAs have been shown to
participate in neurological diseases and neural system
function. For instance, miR-7a was reported to be involved
in glioblastoma [26] and Parkinson’s disease [27]. MiR-27a
and MiR-129 were shown to play a role in autism spec-
trum disorder (ASD) [28]. MiR-320 was observed to be
involved in neurodegenration [12] and retinoblastoma
[29]. MiR-342-3p has been found to play a role in neuro-
degenration [12] and prion disease [30]. Our results indi-
cate that RDX could induce neurological diseases and
neurotoxicity through regulating these miRNAs.
The putative targets of RDX regulated miRNAs involved
in neurotoxicity
Existing studies have exhibited that RDX exposure
induced adverse central nervous system (CNS) syn-
dromes such as convulsion, epileptic seizure, and loss of
reflexes in human and experimental animals [1,5-7].
However, how RDX causes neurotoxicity at molecular
level is not well known. Through the functional analyses
of these target genes, we found that multiple evidences to
support that RDX affects neural system development and
neurological pathways. Nervous system development and
Figure 5 Comparison of canonical pathways based on the
putative target genes of RDX regulated miRNAs and
differentiated mRNA genes. Overlapped all mapped pathways (A)
or significant pathways (B) based on the putative target genes of
RDX regulated miRNAs and differentiated mRNA genes, are
presented in the Venn diagrams. The IPA tool was used for the
pathway analyses. A pathway enrichment p value less than 0.05 was
considered as significant. The overlapped significant pathway names
and their significance are depicted too (C).
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function is in the top significant physiological system
development and function category (Figure 3A). Axonal
guidance signaling pathway is in the top 2 significantly
pathways enriched in the canonical pathway analysis
(Figure 3B). The pathway plays a crucial role in neuronal
connections that are formed by the extension of axons,
which migrate to reach their synaptic targets. The axonal
growth cone, located at the axon leading edge, contains
receptors that sense attractive and repulsive guidance
cues, which help navigate the axon to its final destination
[31-35].
Another important pathway in the top significant path-
way list (Figure 3B) is reelin signaling in neurons. Reelin
is a large extracellular glycoprotein involved in the devel-
opment of architectonic patterns, and Cajal-Retzius cells
of the human embryonic marginal zone are the primary
site of synthesis for reelin. In the hippocampus, reelin
also regulates the growth and/or distribution of afferent
entorhinal and commissural axons. The genes in the
pathway provide molecular mechanisms that control
brain development and, potentially, the pathogenesis of
neurodegenerative disorders [36-38]. Moreover, the most
significant gene network based on the putative target
genes is involved in neural system function and develop-
ment (Figure 4). Regulating the gene network and the
pathways could partially explain the molecular mechan-
ism for RDX induced neurotoxicity.
Figure 6 Gene network using immune and inflammation response genes from both the putative target genes of RDX regulated
miRNAs and differentiated mRNA genes. The network indicates that RDX could first modulate miRNA expression and then trigger an
immune and inflammation gene network by indirectly regulating some immune and inflammation response genes. The network was built using
the IPA tool. Nodes colored in red or green denote up-regulated and down-regulated genes respectively.
Figure 7 Verification of miRNA microarray responses using real
time QRT-PCR. The fold changes represent the expression values of
the miRNAs of the RDX-treated versus control samples. Values refer to
the mean ± SD of three independent samples, each run in triplicate.
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Overlapped genes between putative targets of regulated
miRNAs and differential mRNA genes revealing new
markers for RDX induced neurotoxicity
We found 15 overlapped genes, which are about 12% of
differential mRNA genes (123 genes). The number is
not big and the percentage is similar to other studies.
For instance, the overlapped target genes was 12% in
prion induced miRNA and mRNA profiles [12]. The
Several reasons could account for the small portion of
overlapping. First, the rat mRNA array is not the whole
genome array, only about one third of the genome
(8000 probes) is used, but the prediction of miRNA tar-
gets is based on the whole genome. Second, the predic-
tion is static, which means the targets are predicted
based on any condition, but the mRNA genes are differ-
entially expressed at a certain condition. Third, the pre-
dictive putative targets may contain many false positives.
Fourth, technical limitation for both miRNA and mRNA
arrays may also leave out potential overlapped genes.
We did see an inverse relationship between the regu-
lated miRNA expression and their target mRNA genes
(Table 3). However, we also observed a positive relation-
ship between the expression of the miRNA and their tar-
get genes (Table 3). Normally the enhancement of miRNA
expression inhibits target mRNA expression, but it could
also facilitate target mRNA expression [16,17]. Over half
of the overlapped target genes are involved in neurological
disease and nervous system function (Table 4). If we only
consider the inverse correlation between miRNAs and
their target genes, particularly those target genes involved
in neurological function that are repressed due to the
over-expression of the regulated miRNAs, several target
genes stand out and are SULF1, C5ORF13, ROCK2,
POLE4. SULF1 is necessary for sprouting of neurite, and is
involved in neurological disorder, ischemic stroke and
bipolar disorder [39]. C5ORF13 plays a role in accelerating
nerve regeneration of the axtomized facial nerve and has
been found to involve in multiple neurological diseases
[40]. ROCK2, a Rho-associated, coiled-coil containing pro-
tein kinase, is involved in reaction of neurites [41]. POLE4
also contributes to multiple neurological diseases (Table
4). Here we also want to point out one target gene
HMGCR whose expression is increased by RDX. It has
been found to its over expression could induce stroke and
seizure [42,43]. The up-regulation of HMGCR could be
one reason for RDX induced stroke and seizure. But we
only found up-regulated miRNAs miR-27a and miR-27b
that could target HMGCR. There may be unknown miR-
NAs that target HMGCR and are down-regulated by
RDX. Therefore, based on both miRNA and mRNA pro-
files, we come out a hypothetic model that could partially
explain RDX trigged neurological disorder and neurotoxi-
city. RDX could first induce the expression of miR-71,
miR-27ab, miR-98, and miR-135a, then reduce the
expression of POLE4, C5ORF13, SULF1 and ROCK2, and
finally induce neurotoxicity. RDX induced miR-27ab over-
expression, or reduce the expression of unknown miRNAs,
could consequently up-regulate HMGCR expression to
cause neurotoxicity too (Figure 8). The miRNAs and
genes in the model could be new biomarkers for RDX
induced neurotoxicity, which could work together with
RDX binding to GABAa receptor to explain RDX caused
brain damage.
MiRNAs mediated gene network of immune and
inflammation response genes regulated by RDX
Immune and inflammation response genes are highly
enriched in differentially expressed mRNAs after exposure
to RDX, but not in the putative target genes of regulated
miRNAs. Interestingly, the immune and inflammation
response genes connected network (Figure 6) indicates
that RDX could first modulate miRNA expression and
then trigger an immune and inflammation gene network.
For instance, miR-98 could target IL10, which then up-re-
gulate TNF, which induces the expression of the transcrip-
tion factor HSF1 (Figure 6), to carry out immune
functions. RDX regulated immune response could contri-
bute to RDX induced neurotoxicity and other toxicities as
well as animal defending reaction response to RDX
exposure.
Conclusions
Our results demonstrate that integrating miRNA and
mRNA profiles is valuable to indentify novel biomarkers
and molecular mechanisms for RDX-induced neurological
disorder and neurotoxicity. RDX could first induce the
expression of miR-71, miR-27ab, miR-98, and miR-135a,
Figure 8 A hypothetical model to explain the molecular
mechanisms of RDX-induced neurological disorder and
neurotoxicity. RDX could first up-regulate the expression of miR-71,
miR-27ab, miR-98, and miR-135a, then reduce the expression of the
gens POLE4, C5ORF13, SULF1 and ROCK2, and eventually induce
neurotoxicity. Over-expression of miR-27ab, or reduction of the
expression of unknown miRNAs by RDX, could up-regulate HMGCR
expression to cause neurotoxicity too.
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then reduce the expression of POLE4, C5ORF13, SULF1
and ROCK2, and finally induce neurotoxicity, which pro-
vides an alternative mechanism to explain RDX induced
neurotoxicity.
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